Oral Surgery · patient case with 5 questions
Exposed Bone After an Extraction
Patient: 68-year-old male
Chief Complaint: “The bone is showing where they pulled my tooth, and it smells bad.”
Background: Metastatic prostate carcinoma with bone metastases, on monthly intravenous zoledronic acid for 3 years. Tooth #30 extracted 10 weeks ago at another office. No history of head and neck radiation. Non-smoker.
Medications: Zoledronic acid IV monthly · Leuprolide · Calcium and vitamin D
Vital Signs: BP 132/80 mmHg · HR 76 bpm · RR 16 · T 99.1°F
Findings: A 15 mm area of exposed, necrotic-appearing bone at the #30 site with purulent drainage and surrounding erythema. No extraoral fistula. Teeth #29 and #31 are present, sound, and periodontally stable. The patient asks about replacing #30 with an implant once the site heals.
Question 1
What is the most likely diagnosis?
Show answer and explanation
Correct answer: B. Medication-related osteonecrosis of the jaw
- A. Incorrect. Metastatic disease to the mandible typically presents as an ill-defined destructive radiolucency, sometimes with paresthesia of the lower lip. It does not present as chronically exposed bone at an extraction site.
- B. Correct. Exposed necrotic bone persisting beyond 8 weeks, in a patient on an antiresorptive agent, with no history of radiation to the jaws, meets the diagnostic definition. Purulence and erythema without extraoral fistula place this at stage 2.
- C. Incorrect. Osteomyelitis arises from an odontogenic infection spreading into marrow spaces, with characteristic radiographic sequestra and periosteal reaction. The antiresorptive history and the classic timeline point elsewhere.
- D. Incorrect. Osteoradionecrosis requires prior therapeutic radiation to the head and neck. His radiation, if any, was directed at the pelvis, and the stem explicitly excludes head and neck radiation.
Note: Diagnostic triad: current or previous antiresorptive or antiangiogenic therapy, exposed bone or a probeable fistula persisting more than 8 weeks, and no history of radiation to the jaws.
Question 2
What is the most appropriate initial management?
Show answer and explanation
Correct answer: D. Antimicrobial rinses and systemic antibiotics, avoiding surgical exploration
- A. Incorrect. Hyperbaric oxygen has a defined role in osteoradionecrosis. Its benefit in medication-related osteonecrosis is not established and it is not first-line.
- B. Incorrect. Aggressive surgical intervention in this setting frequently enlarges the lesion. Bone in an antiresorptive-treated jaw has a markedly impaired capacity to heal a surgical wound.
- C. Incorrect. Resection is reserved for stage 3 disease — pathologic fracture, extraoral fistula, oroantral communication, or osteolysis extending to the inferior border.
- D. Correct. Stage 2 disease is managed conservatively: chlorhexidine rinses, systemic antibiotics for the secondary infection, analgesia, and superficial debridement only to relieve soft tissue irritation. Surgery risks extending the necrotic field into previously unaffected bone.
Question 3
To which specialist should this patient be referred?
Show answer and explanation
Correct answer: A. Oral and maxillofacial surgeon
- A. Correct. Management requires staging, long-term surveillance, and the capacity to perform resective surgery should the disease progress. Coordination with his oncologist regarding any drug holiday is also part of that referral pathway.
- B. Incorrect. A periodontist manages periodontal and peri-implant disease and performs regenerative and mucogingival surgery. This lesion falls outside that scope.
- C. Incorrect. Prosthetic rehabilitation may eventually be considered, but only long after the osteonecrosis is controlled.
- D. Incorrect. The lesion is at an extraction site, not associated with a pulp. There is nothing endodontic to treat.
Question 4
If an implant is eventually planned in the mandibular posterior region, what is the minimum safe vertical distance between the implant apex and the superior border of the inferior alveolar canal?
Show answer and explanation
Correct answer: C. 2 mm
- A. Incorrect. Half a millimeter falls well within the error range of any radiographic technique and offers no meaningful protection to the nerve.
- B. Incorrect. Five millimeters is more conservative than required and would unnecessarily restrict implant length in an atrophic ridge.
- C. Correct. A 2 mm safety zone is the accepted minimum. It accommodates radiographic magnification and distortion, surgical drill overrun, and anatomic variation in canal position, protecting against paresthesia of the lower lip and chin.
- D. Incorrect. Eight millimeters would eliminate implant placement as an option in most posterior mandibles.
Note: Related safety margins worth memorizing: 1.5 mm from an implant to an adjacent natural tooth root, 3 mm between two adjacent implants, and 1 mm of bone on the buccal and lingual plates.
Question 5
What is the minimum mesiodistal space required between two adjacent natural teeth to place a single standard-diameter implant?
Show answer and explanation
Correct answer: A. 7 mm
- A. Correct. The arithmetic is straightforward: approximately 4 mm for a standard-diameter fixture plus 1.5 mm of clearance to each adjacent root equals 7 mm. Anything narrower requires a reduced-diameter implant or orthodontic space opening.
- B. Incorrect. Five millimeters leaves less than 1 mm of clearance on each side, which risks damage to adjacent periodontal ligaments and compromises the interproximal bone that supports the papilla.
- C. Incorrect. Ten millimeters is generous and comfortable, but well above the stated minimum requirement.
- D. Incorrect. That figure is roughly the diameter of a narrow implant alone, with no allowance for clearance to either adjacent root.